Like a woman’s libido, the name of the new drug approved to treat female sexual dysfunction is hard to understand—let alone pronounce. Yes, as if women struggling with hypoactive sexual desire ...
Hosted on MSN
Meet the Addyi pill, a.k.a. pink Viagra: Why the FDA's new 2025 approval is a ‘historic first' for women over 50
Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally entering the long-overdue conversation. The FDA recently approved the use ...
What Is Addyi, and Why Does It Matter? Addyi (flibanserin) is a nonhormonal prescription pill that is now approved by the FDA to treat low sexual desire in women younger than 65, including those who ...
RALEIGH, N.C., Jan. 29, 2026 /PRNewswire/ -- Sprout Pharmaceuticals today announced that Addyi® has been named "Best Prescription for Low Libido" in the 2026 Oprah Daily Menopause O-wards, one of the ...
Credit: Sprout Pharmaceuticals The approval was based on a randomized, double-blind, placebo-controlled phase 3 trial, which included 447 postmenopausal women with acquired, generalized HSDD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results